Literature DB >> 27888133

Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment.

Jiansong Fang1, Ling Wang2, Tian Wu1, Cong Yang1, Li Gao3, Haobin Cai1, Junhui Liu4, Shuhuan Fang1, Yunbo Chen1, Wen Tan5, Qi Wang6.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Alzheimer's disease (AD), as the most common type of dementia, has brought a heavy economic burden to healthcare system around the world. However, currently there is still lack of effective treatment for AD patients. Herbal medicines, featured as multiple herbs, ingredients and targets, have accumulated a great deal of valuable experience in treating AD although the exact molecular mechanisms are still unclear.
MATERIALS AND METHODS: In this investigation, we proposed a network pharmacology-based method, which combined large-scale text-mining, drug-likeness filtering, target prediction and network analysis to decipher the mechanisms of action for the most widely studied medicinal herbs in AD treatment.
RESULTS: The text mining of PubMed resulted in 10 herbs exhibiting significant correlations with AD. Subsequently, after drug-likeness filtering, 1016 compounds were remaining for 10 herbs, followed by structure clustering to sum up chemical scaffolds of herb ingredients. Based on target prediction results performed by our in-house protocol named AlzhCPI, compound-target (C-T) and target-pathway (T-P) networks were constructed to decipher the mechanism of action for anti-AD herbs.
CONCLUSIONS: Overall, this approach provided a novel strategy to explore the mechanisms of herbal medicine from a holistic perspective.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer; Berberine (PubChem CID: 2353); Crocin (PubChem CID: 5281233); Cryptotanshinone (PubChem CID: 160254); Curcumin (PubChem CID: 969516); Ginsenoside Rd (PubChem CID: 11679800); Ginsenoside Rg1 (PubChem CID: 441923); Ginsenoside Rg2 (PubChem CID: 75412551); Ginsenoside Rg3 (PubChem CID: 9918693); Ginsenoside Rg5 (PubChem CID: 44416768); Herbal medicines; Network pharmacology; Salvianolic acid A (PubChem CID: 5281793); Salvianolic acid B (PubChem CID: 11629084); Tanshinone IIA (PubChem CID: 164676); Target prediction; Tenuifolin (PubChem CID: 21588226); kaempferol (PubChem CID: 5280863); quercetin (PubChem CID: 5280343)

Mesh:

Substances:

Year:  2016        PMID: 27888133     DOI: 10.1016/j.jep.2016.11.034

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  35 in total

1.  Cryptotanshinone Attenuates Amyloid-β42-induced Tau Phosphorylation by Regulating PI3K/Akt/GSK3β Pathway in HT22 Cells.

Authors:  Diyang Lyu; Jianping Jia
Journal:  Mol Neurobiol       Date:  2022-05-16       Impact factor: 5.590

2.  Bibliometric Analysis of Network Pharmacology in Traditional Chinese Medicine.

Authors:  Runpei Miao; Qinggang Meng; Chennan Wang; Wenjing Yuan
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-15       Impact factor: 2.650

3.  Meloxicam Inhibits Apoptosis in Neurons by Deactivating Tumor Necrosis Factor Receptor Superfamily Member 25, Leading to the Decreased Cleavage of DNA Fragmentation Factor Subunit α in Alzheimer's Disease.

Authors:  Peipei Guan; Di Zhu; Pu Wang
Journal:  Mol Neurobiol       Date:  2022-10-24       Impact factor: 5.682

4.  Suppression of MIF-induced neuronal apoptosis may underlie the therapeutic effects of effective components of Fufang Danshen in the treatment of Alzheimer's disease.

Authors:  Cheng-Jie Liang; Jia-Huang Li; Zhen Zhang; Ju-Yan Zhang; Shu-Qun Liu; Jie Yang
Journal:  Acta Pharmacol Sin       Date:  2018-05-17       Impact factor: 6.150

5.  Systems pharmacology approach uncovers Ligustilide attenuates experimental colitis in mice by inhibiting PPARγ-mediated inflammation pathways.

Authors:  Yujie Huang; Yifan Zhang; Ting Wan; Yu Mei; Zihao Wang; Jincheng Xue; Yi Luo; Min Li; Shuhuan Fang; Huafeng Pan; Qi Wang; Jiansong Fang
Journal:  Cell Biol Toxicol       Date:  2020-10-31       Impact factor: 6.691

6.  Differential Metabolomics and Network Pharmacology Analysis of Silkworm Biotransformation between Mulberry Leaves and Silkworm Droppings.

Authors:  Mingqian Li; Lin Chen; Yuntao Dai; Jiacheng Li; Fei Li; Qun Li; Zhihong Yu; Kequn Chai; Yongqiang Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-29       Impact factor: 2.629

7.  How impaired efficacy happened between Gancao and Yuanhua: Compounds, targets and pathways.

Authors:  Jin-Gao Yu; Jianming Guo; Kevin Yue Zhu; Weiwei Tao; Yanyan Chen; Pei Liu; Yongqing Hua; Yuping Tang; Jin-Ao Duan
Journal:  Sci Rep       Date:  2017-06-19       Impact factor: 4.379

8.  The Mechanisms of Bushen-Yizhi Formula as a Therapeutic Agent against Alzheimer's Disease.

Authors:  Haobin Cai; Yunxia Luo; Xin Yan; Peng Ding; Yujie Huang; Shuhuan Fang; Rong Zhang; Yunbo Chen; Zhouke Guo; Jiansong Fang; Qi Wang; Jun Xu
Journal:  Sci Rep       Date:  2018-02-15       Impact factor: 4.379

9.  The mechanism and candidate compounds of aged citrus peel (chenpi) preventing chronic obstructive pulmonary disease and its progression to lung cancer.

Authors:  Lin Zhou; Wenwen Gu; Fuguang Kui; Fan Gao; Yuji Niu; Wenwen Li; Yaru Zhang; Lijuan Guo; Junru Wang; Zhenzhen Guo; Gangjun Du
Journal:  Food Nutr Res       Date:  2021-05-17       Impact factor: 3.894

10.  Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation.

Authors:  Li Gao; Ke-Xin Wang; Yu-Zhi Zhou; Jian-Song Fang; Xue-Mei Qin; Guan-Hua Du
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.